Skip Navigation


Glycobiology Advance Access originally published online on January 31, 2006
Glycobiology 2006 16(5):440-461; doi:10.1093/glycob/cwj081
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/5/440    most recent
cwj081v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Faid, V.
Right arrow Articles by Morelle, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faid, V.
Right arrow Articles by Morelle, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Site-specific glycosylation analysis of the bovine lysosomal {alpha}-mannosidase

Valegh Faid2, Gry Evjen3, Ole-Kristian Tollersrud3, Jean-Claude Michalski2, and Willy Morelle1,2

2 Unité Mixte de Recherche CNRS/USTL 8576, «Glycobiologie Structurale et Fonctionnelle», IFR 118, Bâtiment C9, Université des Sciences et Technologies de Lille 1, 59655 Villeneuve d’Ascq Cedex, France; and 3 Department of Medical Biochemistry, Institute of Medical Biology, University of Tromsø, 9037 Tromsø, Norway


1 To whom correspondence should be addressed; e-mail: willy.morelle{at}univ-lille1.fr

Received on December 7, 2005; revised on January 23, 2006; accepted on January 23, 2006


    Abstract
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
Lysosomal {alpha}-mannosidase is a broad specificity exoglycosidase involved in the ordered degradation of glycoproteins. The bovine enzyme is used as an important model for understanding the inborn lysosomal storage disorder {alpha}-mannosidosis. This enzyme of about 1000 amino acids consists of five peptide chains, namely a- to e-peptides and contains eight N-glycosylation sites. The N497 glycosylation site of the c-peptide chain is evolutionary conserved among LAMANs and is very important for the maintenance of the lysosomal stability of the enzyme. In this work, relying on an approach based on mass spectrometric techniques in combination with exoglycosidase digestions and chemical derivatizations, we will report the detailed structures of the N-glycans and their distribution within six of the eight N-glycosylation sites of the bovine glycoprotein. The analysis of the PNGase F-released glycans from the bovine LAMAN revealed that the major structures fall into three classes, namely high-mannose-type (Fuc0–1Glc0–1Man4–9GlcNAc2), hybrid-type (Gal0–1Man4–5GlcNAc4), and complex-type (Fuc0–1Gal0–2Man3GlcNAc3–5) N-glycans, with core fucosylation and bisecting GlcNAc. To investigate the exact structure of the N-glycans at each glycosylation site, the peptide chains of the bovine LAMAN were separated using SDS–PAGE and in-gel deglycosylation. These experiments revealed that the N497 and N930 sites, from the c- and e-peptides, contain only high-mannose-type glycans Glc0–1Man5–9GlcNAc2, including the evolutionary conserved Glc1Man9GlcNAc2 glycan, and Fuc0–1Man3–5GlcNAc2, respectively. Therefore, to determine the microheterogeneity within the remaining glycosylation sites, the glycoprotein was reduced, carboxymethylated, and digested with trypsin. The tryptic fragments were then subjected to concanavalin A (Con A) affinity chromatography, and the material bound by Con A-Sepharose was purified using reverse-phase high-performance liquid chromatography (HPLC). The tandem mass spectrometry (ESI-MS/MS) and the MALDI analysis of the PNGase F-digested glycopeptides indicated that (1) N692 and N766 sites from the d-peptide chain both bear glycans consisting of high-mannose (Fuc0–1Man3–7GlcNAc2), hybrid (Fuc0–1 Gal0–1Man4–5GlcNAc4), and complex (Fuc0–1Gal0–2Man3GlcNAc4–5) structures; and (2) the N367 site, from the b-peptide chain, is glycosylated only with high-mannose structures (Fuc0–1Man3–5GlcNAc2). Taking into consideration the data obtained from the analysis of either the in-gel-released glycans from the abc- and c-peptides or the tryptic glycopeptide containing the N367 site, the N133 site, from the a-peptide, was shown to be glycosylated with truncated and high-mannose-type (Fuc0–1Man4–5GlcNAc2), complex-type (Fuc0–1Gal0–1Man3GlcNAc5), and hybrid-type (Fuc0–1Gal0–1Man5GlcNAc4) glycans.

Key words: {alpha}-mannosidosis / glycosylation sites / lysosomal storage disorder / mass spectrometry / structure analysis


    Introduction
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
Lysosomal {alpha}-mannosidase (LAMAN; EC 3.2.1.24 [EC] ) belonging to class II {alpha}-mannosidases is an exoglycosidase that cleaves all {alpha}-mannosyl linkages known during the degradation of N-linked oligosaccharides (Aronson and Kuranda, 1989Go). LAMAN is expressed in all tissues and in many species. This enzyme is characterized by broad natural substrate specificity, its sensitivity to the swainsonine inhibitor, its capacity to retain the anomeric configuration of the related mannae residues (Howard-et-al-1997Howard et al., 1997), and its capability to hydrolyze p-nitrophenylmannopyranoside (for review, see Daniel et al., 1994; Moremen et al., 1994). Contrary to the other members of the sequence-based glycoside–hydrolase family 38 (GH 38) (Henrissat and Bairoch, 1993Go), LAMAN is characterized by low-pH activation (Heikinheimo et al., 2003Go), depending on the intracellular location on the lysosome and lack of activity at neutral pH.

Numerous metabolic studies, particularly on human LAMAN (Pohlmann et al., 1983Go; Cheng et al., 1986Go; Tsuji and Suzuki, 1987Go; Nilssen et al., 1997), have shown that the enzyme is synthesized as a single-chain precursor close to 110 kDa, which is further proteolytically processed into several peptides (two to 10) during its intracellular traffic from the endoplasmic reticulum (ER) to the lysosome. These evolutionary preserved cleavages play no physiological role, since the enzyme exists as a functionally single-chain polypeptide (Berg et al., 1999Go). Human LAMAN consists of two immunologically identical isoforms A and B, which are selectively separated by ion-exchange chromatography and differ in their isoelectric point, arising from different states of sialylation and/or phosphorylation of mannose residues (Cheng et al., 1986Go). The human enzyme is first synthesized as three glycopeptides of 70, 42, and 15 kDa, generated from the proteolysis of 110 kDa chain precursor which is partly secreted into the extracellular medium. The 70-kDa glycopeptide will further undergo a second proteolytic process on its way to the lysosome to produce three more glycopeptides, joined by two disulfide bridges. Moreover, another post-translational modification appears to be evolutionary conserved involving one N-glycosylation consensus site (497N-I/V-S/T499) and two proximate cysteines (C493 and C501) organized as a loop. This structural modification appears to be essential for the maintenance of lysosomal stability.

Lack of this enzyme causes a lysosomal storage disorder, named {alpha}-mannosidosis (OMIM 248500 [OMIM] ). This genetic defect is responsible for a massive accumulation of unprocessed mannose-containing oligosaccharides within lysosomes in most cell types of patients, resulting in varying neural, immune, and skeletal abnormalities. Patients are characterized by varying clinic presentations including mental retardation, recurrent infections, hearing loss, hepatosplenomegaly, and dysostosis multiplex as the most known (Thomas and Beaudet, 1995Go; Michalski, 1996; Michalski and Klein, 1999Go). {alpha}-Mannosidosis is known to occur in human (Nilssen et al., 1997Go), cattle (Berg, Healy, et al., 1997Go; Tollersrud et al., 1997Go), Persian cat (Berg, Tollersrud, et al., 1997Go), and guinea pig (Berg and Hopwood, 2001Go), and a gene knockout model in mice has been established. Several groups have cloned the LAMAN gene (MANB), comprising 24 exons, spanning 21.5 kb and located in chromosome 19p13.2-q12 (Liao et al., 1996Go; Nilssen et al., 1997Go; Riise et al., 1997Go). More than 50 {alpha}-mannosidosis-causing mutations have been reported (Nilssen et al., 1997Go; Gotoda et al., 1998Go; Berg et al., 1999Go). These disease-causing mutations are responsible for the total or partial inactivation of LAMAN by disturbing its intracellular traffic (Hansen et al., 2004Go), structure, and activity (Heikinheimo et al., 2003Go).

The bovine enzyme is an important molecular model for understanding the human enzyme and pathophysiology of {alpha}-mannosidosis. Heikinheimo et al. (2003)Go have recently solved its three-dimensional structure, the first structure of a mammalian enzyme in GH 38 family, providing a basis for understanding the human disease at the atomic level. The active site, formed by the a- and b-peptides, is located to the N-terminal side and is formed on the top of a distorted seven-stranded {alpha}/ß-barrel. Following the barrel domain, the structure consists of a three-helix bundle, joining the b- and c-peptides, and three subsequent ß-sheet domains, formed by c-, d-, and e-peptides, with unknown function. In addition, the lysosomal enzyme has a large evolutionary conserved carbohydrate chain at the N497 glycosylation site, resting ordered against the three-helix bundle. The structure suggests signal areas for mannose phosphorylation and a low-pH activation mechanism. The bovine LAMAN is about 250 kDa homodimeric glycoprotein. The matching monomer is synthesized as a 110 kDa precursor of about 1000 amino acids, which is further post-translationally modified by N-glycosylation, disulfide bridge formation, and proteolysis into five glycopeptides named a, b, c, d, and e of 35/38, 11/13, 22, 38, and 13/15 kDa, respectively (Tollersrud et al., 1997Go). The a-, b-, and c-peptides are linked by two disulfide bridges, d- and e-peptides being linked via salt bridge networks (Tollersrud et al., 1997Go; Heikinheimo et al., 2003Go). Since the carbohydrate moiety plays many key roles in the biology of most cellular glycoproteins, such as resistance against proteolysis, folding, or intracellular trafficking (for reviews see Varki, 1993Go; Parodi, 2000Go; Helenius and Aebi, 2001Go, 2004Go; Spiro, 2002; Trombetta, 2003Go), bovine LAMAN glycosylation has been investigated. Indeed, eight putative N-glycosylation sites (N133, N367, N497, N645, N651, N692, N766, and N930) were present within the polypeptide backbone. Molecular shift analysis of the bovine enzyme by SDS–PAGE after endo-ß-N-acetylglucosaminidase H (endoH) and/or peptidyl-N-glycosidase F (PNGase F) treatments suggested that all potential sites are glycosylated (Tollersrud et al., 1997Go). Then, depending on their endoH resistance, it was possible to conclude that a-peptide (N133) and most sites of d-peptide (N645, N651, N692, and N766) are occupied by complex-type N-glycans. b- (N367) and c- (N497) peptides are exclusively occupied by oligomannose-type and/or hybrid-type N-glycans. With respect to e-peptide (N930), complex-type with oligomannose-type and/or hybrid-type N-glycans are present. N-glycosylation site N497 is conserved in all LAMANs from plants to mammals (Berg T, Hansen GM, et al., in preparation). In addition, an unusual monoglucosylated oligomannose glycan (Glc1Man9GlcNAc2) carried by N-glycosylation site N497 has also been described. This atypical structure is a retention signal for the calnexin/calreticulin quality-control pathway in the ER (for reviews see Rudd and Dwek, 1997Go; Parodi, 2000Go; Spiro, 2002Go; Trombetta, 2003; Helenius and Aebi, 2004Go; Trombetta and Parodi, 2005Go). The presence of this monoglucosylated oligomannose-type glycan in a mature and secreted glycoprotein indicates that the oligosaccharide is located in a region which is not folded by the calnexin/calreticulin system and prevents the removal of the terminal glucose residue by ER-{alpha}-glucosidase II (Crispin et al., 2004).

So far, no data have been reported about the detailed structure of N-glycans or about the site occupancy of the eight N-glycosylation sites. To understand the functions of N-glycans in the biology of LAMANs, we have elucidated the detailed structures of all N-glycans in the bovine LAMAN on one hand and their distribution within each site of N-glycosylation on the other hand.


    Results
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
LAMAN isolation
Bovine LAMAN (primary access number Swiss-Prot: Q29451 [GenBank] ) was isolated from homogenized Bos Taurus kidney, as published previously (Tollersrud et al., 1997Go).

Strategy for determining the structure of the major glycans released from the bovine LAMAN
The general strategy employed for investigating glycosylation pattern of the bovine LAMAN is outlined in Scheme 1.


Figure 1
View larger version (19K):
[in this window]
[in a new window]
 
Scheme 1. Strategy dedicated to the determination of the structures of the N- and O-linked glycans of the bovine LAMAN.

 

The detailed structures of glycans of the bovine LAMAN have been determined after digestion by trypsin of the reduced carboxamidomethylated glycoprotein. Glycans were then released from the resulting peptide/glycopeptide mixture by digestion with PNGase F. The PNGase F-released N-glycans were separated from peptides using a C18 Sep-Pak cartridge and desalted on nonporous graphitized carbon solid-phase extraction cartridge. Because of the availability of only limited amounts of material, the oligosaccharides were analyzed as mixtures. PNGase F-released N-glycans were characterized by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) before and after on-plate sequential exoglycosidase digestions. Their methylated derivatives were also characterized by MALDI-MS before and after sequential exoglycosidase digestions and by linkage analysis. Structural assignments were based on molecular weight, susceptibility to exoglycosidase digestions, and linkage data. Putative O-glycans were released by reductive elimination, permethylated, purified on a C18 Sep-Pak cartridge, and analyzed by MALDI-MS.

Determination of the structure of N-glycans released from bovine LAMAN
Monosaccharide composition of PNGase F-released glycans The monosaccharide composition of the PNGase F-released N-glycans from bovine LAMAN was determined by GC-MS analysis of the heptafluorobutyrate derivatives of the methyl glycosides. The data revealed the presence of Fuc, Gal, Glc, Man, and GlcNAc residues at a molar ratio of approximately 2:1:0,3:6:1, respectively (data not shown). These results suggest that the major N-glycans of bovine LAMAN have compositions consistent with high-mannose-type structures. Moreover, the same experiment has been reproduced on the entire glycoprotein to determine the carbohydrate content which was of about 10% (w/w), and no GalNAc residues have been detected. This last observation suggests that no O-glycans are present within the polypeptide backbone of the bovine LAMAN.

MALDI-MS analysis of the PNGase F-released glycan The desalted PNGase F-released N-glycans were analyzed by MALDI-MS. The data from the MALDI-MS analysis are shown in Figure 1A and summarized in Table I. A very heterogeneous mixture of oligosaccharides was observed, affording about 20 pseudomolecular ions [M+Na]+. From their m/z ratio, monosaccharide compositions in terms of Hex, dHex, and HexNAc of each PNGase F-released oligosaccharide from bovine LAMAN have been determined and are summarized in Table I. Based on the MALDI-MS data and currently accepted models of eukaryotic N-glycan biosynthesis, these data indicate that bovine LAMAN contains glycans having a composition consistent with high-mannose structures (Fuc0–1Hex4–10HexNAc2; including the evolutionary conserved monoglucosylated oligomannosidic glycan Glc1Man9GlcNAc2), hybrid structures (Hex4–6HexNAc4), and complex structures (Fuc0–1Hex3–5HexNAc3–5). Notable features of these data are as follows: (1) oligomannosidic structures are more abundant than complex structures; and (2) most of the complex structures have compositions consistent with bi- and/or triantennary structures. It is important to note that compositions consistent with isobaric complex and hybrid structures were differentiated according to their endoH sensitivity (data not shown). Indeed, endoH releases only high-mannose and hybrid-type N-glycans from glycoproteins. The native N-glycans were also analyzed in the negative mode. No signals were detected, suggesting that no acidic structures (phosphorylated, sulfated, or sialylated) were present (data not shown).


Figure 1
View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1. MALDI-MS spectra of PNGase F-released N-glycans from bovine LAMAN (A), after treatment with ß-galactosidase (B), after treatment with ß-galactosidase and ß-N-acetylhexosaminidase (C), after treatment with ß-galactosidase, ß-N-acetylhexosaminidase and after treatment with {alpha}-mannosidase (D). Bovine LAMAN was reduced, alkylated, and digested with trypsin. Glycans were then released from the resulting peptides/glycopeptides by digestion with PNGase F. PNGase F-released glycans were separated from peptides using a C18 Sep-Pak cartridge and desalted on a nonporous graphitized carbon solid-phase extraction cartridge. The glycans were then analyzed in positive ion reflective mode before and after on-target exoglycosidase digestions, as [M+Na]+ pseudomolecular ions. a, GlcNAc may be linked to either arm, forming a triantennary structure (1–4 or 1–6 linkage) or the core ß-linked mannose to form a bisected structure (1–4 linkage). b, Gal may be attached to any arm.

 

View this table:
[in this window]
[in a new window]
 
Table I. Assignment of pseudomolecular ion [M+Na]+ observed in MALDI-MS spectrum of the PNGase F-released N-glycans from bovine LAMAN

 

Sequential exoglycosidase digestion of the PNGase F-released glycan mixture of the bovine LAMAN To determine the carbohydrate sequence as well as the anomeric configurations, the PNGase F-released glycans were subjected to on-plate treatments with an array of exoglycosidases and then analyzed by MALDI-MS (Mechref and Novotny, 1998Go) (Figure 1B–D). After treatment with ß-galactosidase (Figure 1B), the pseudomolecular ions [M+Na]+ at m/z 1704 (Hex4HexNAc5), 1825 (Hex6HexNAc4), 1850 (dHex1Hex4HexNAc5), 1866 (Hex5HexNAc5), and 2012 (dHex1Hex5HexNAc5) were significantly reduced in intensity, with a significant concomitant increase in the abundance of the molecular ions at m/z 1542 (Hex3HexNAc5), 1663 (Hex5HexNAc4), and 1688 (dHex1Hex3HexNAc5), consistent with the removal of one or two terminal ß-Gal residues. The combined digestions with ß-galactosidase and ß-N-acetylhexosaminidase (Figure 1C) have greatly simplified the MALDI-MS spectrum, which is now characterized by several major pseudomolecular ions [M+Na]+ at m/z 933 (Hex3HexNAc2), 1079 (dHex1Hex3HexNAc2), 1257 (Hex5HexNAc2), 1419 (Hex6HexNAc2), 1581 (Hex7HexNAc2), 1743 (Hex8HexNAc2), and 1905 (Hex9HexNAc2). All these species were unaffected by the above exoglycosidase digestions, a result that is consistent with the assignment of high-mannose structures to these ions. Minor molecular ions were also observed at m/z 1095 (Hex4HexNAc2), 1403 (dHex1Hex5HexNAc2), and 2067 (Hex10HexNAc2). The molecular species at m/z 1339 (Hex3HexNAc4), 1501 (Hex4HexNAc4), 1542 (Hex3HexNAc5), 1663 (Hex5HexNAc4), and 1688 (dHex1Hex3HexNAc5) were efficiently digested by ß-N-acetylhexosaminidase to the products Fuc0–1Hex3HexNAc2 at m/z 1079 and 933, which are consistent with trimannosyl core with and without core fucosylation, respectively. It can then be concluded that the GlcNAc residues of the N-glycans antenna are ß-linked. The disappearance of pseudomolecular ions at m/z 1501 (Hex4HexNAc4) and 1663 (Hex5HexNAc4) is accompanied by a concomitant increase of the relative abundance of the pseudomolecular species at m/z 1095 (Hex4HexNAc2) and 1257 (Hex5HexNAc2), suggesting that these two initial species were consistent with the composition of hybrid structures. After {alpha}-mannosidase treatment (Figure 1D), the molecular ions at m/z 1079 (dHex1Hex3HexNAc2), 1403 (dHex1Hex5HexNAc2), 1257 (Hex5HexNAc2), 1419 (Hex6HexNAc2), 1581 (Hex7HexNAc2), 1743 (Hex8HexNAc2), and 1905 (Hex9HexNAc2) were trimmed to Hex3HexNAc2 at m/z 933 and Fuc1Hex3HexNAc2 at m/z 1079. In addition, the molecular ion at m/z 2067 (Hex10HexNAc2) was abolished, concomitant with the appearance of a new signal at m/z 1743 (Hex8HexNAc2). This new molecular ion is consistent with the loss of two {alpha}-Man residues from the original molecular ion at m/z 2067 (Hex10HexNAc2). After {alpha}-glucosidase II digestion, the molecular ion at m/z 1743 (Hex8HexNAc2) disappeared (data not shown), and a new ion was observed at m/z 1581 (Hex7HexNAc2), confirming then the presence of the evolutionary conserved glucosylated oligomannose-type glycan (Glc1Man9GlcNAc2) on bovine LAMAN (Berg T, Hansen GM, et al., in preparation).

Linkage analysis of the PNGase F-released glycans from the bovine LAMAN To identify the position of glycosidic bonds, PNGase F-released N-glycans from bovine LAMAN were permethylated (Ciucanu and Kerek, 1984Go), analyzed by MALDI-MS, and subjected to GC-MS analysis, as partially methylated alditol acetate derivatives, before and after sequential exoglycosidase digestions. According to the data summarized in Table II, some conclusions could be drawn which are as follows: (1) the abundant 2-linked Man indicates that most of the complex-type N-glycans are biantennary, but minor 2,4-branched Man and 2,6-branched Man suggest that minor tri- and/or tetraantennary structures are present; (2) Fuc, Gal, Man, and GlcNAc are the major nonreducing sugars, but minor terminal Glc was also detected; (3) the abundant terminal mannose is in accordance with high-mannose structures being the major components of the N-glycan population; (4) terminal Fuc and the 4,6-linked GlcNAc residues are consistent with the presence of core-fucosylated glycans; and (5) the high level of 3,4,6-linked Man indicates that most of the hybrid-type and/or the complex-type glycans are core bisected. After ß-galactosidase treatment, terminal Gal disappeared, while a decrease of 4-linked GlcNAc was observed, indicating that nonreducing Gal residues were attached to the 4-position of the GlcNAc residues, prior to ß-galactosidase digestion. Comparison of linkage data before and after ß-N-acetylhexosaminidase treatment indicated that loss of terminal ß-GlcNAc residues is accompanied by a decrease in 2-linked Man, 2,4-linked Man, 2,6-linked Man, and a concomitant increase in terminal Man. Besides, the 3,4,6-linked Man disappeared, and a concomitant increase of 3,6-linked Man was observed. These data indicate that GlcNAc residues were attached to the 4-position of the 3,4,6-linked Man and confirm the presence of core-bisected complex-type glycans and/or hybrid-type glycans. Comparison of linkage data before and after {alpha}-fucosidase treatment indicated that loss of terminal Fuc is accompanied by a loss of the 4,6-linked GlcNAc and a concomitant increase of 4-linked GlcNAc, indicating that Fuc residues were attached to the 6-position of the GlcNAc residues. These data support the presence of ({alpha}1,6)-core fucosylation.


View this table:
[in this window]
[in a new window]
 
Table II. Linkage analysis of partially methylated alditol acetates derivatives of the PNGase F-released N-glycans from bovine LAMAN

 

Assignment of the PNGase F-released glycans mixture of the bovine LAMAN Taking into consideration MALDI-MS, linkage, and sequential exoglycosidase data, we conclude that the major glycans released from bovine LAMAN fall into three classes, namely oligomannose-type (Fuc0–1Glc0–1Man4–9GlcNAc2), hybrid-type (Gal0–1Man4–5GlcNAc4), and complex-type (Fuc0–1Gal0–2Man3GlcNAc3–5) N-glycans (Figure 2). A minor monoglucosylated oligomannosidic N-glycan (Glc1Man9GlcNAc2) is also present and is consistent with the evolutionary conserved structure among LAMANs (Berg T, Hansen GM, et al., in preparation). High-mannose structures are more abundant than hybrid and complex structures. The major complex-type oligosaccharides have compositions consistent with biantennary structures with a bisecting GlcNAc residue and/or triantennary structures without ({alpha}1,6)-core fucosylation. The major nonreducing epitopes in the complex-type glycans are GlcNAc and Gal(ß1–4)GlcNAc. The very low abundance of the minor compounds has to date precluded precise structural analysis.


Figure 2
View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2. Proposed structures for the major PNGase F-released N-glycans from bovine LAMAN. a, GlcNAc may be linked to either arm, forming a triantennary structure (1–4 or 1–6 linkage) or the core ß-linked mannose to form a bisected structure (1–4 linkage). b, Gal may be attached to any arm.

 


    O-glycosylation analysis
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
Reductive elimination on de-N-glycosylated peptides did not give any monosaccharides when analyzed by GC-MS analysis of the heptafluorobutyrate derivatives of the methyl glycosides (data not shown). Putative O-glycans were also permethylated, purified on a C18 Sep-Pak cartridge, and analyzed by MALDI-MS. No signals corresponding to O-glycans were observed (data not shown). Thus, we could find no evidence that O-linked glycans were an important component of the bovine LAMAN.


    Strategy for investigating site-specific glycosylation of the bovine LAMAN
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
After elucidating the structures of the major PNGase F-released N-glycans from the bovine LAMAN, the structure of the N-glycans at each glycosylation site has been determined. Bovine LAMAN consists of five peptide chains, namely a- to e-peptides, each containing one N-glycosylation site, except for the d-peptide that contains four N-glycosylation sites. To obtain information about the glycosylation within each peptide, peptide chains of the bovine LAMAN were electrophoretically separated according to their molecular weight, using SDS–PAGE. Bands of interest were excised, reduced, carboxamidomethylated, and in-gel deglycosylated by treatment with PNGase F, according to the procedure developed by Küster et al. (1997)Go. After desalting on nonporous graphitized carbon solid-phase extraction cartridge, the extracted glycans were finally analyzed by MALDI-MS, before and after on-plate sequential exoglycosidase digestions. After in-gel deglycosylation, identification of each peptide was confirmed by the use of in-gel tryptic digestion followed by MALDI-MS and matching of the mass fingerprint of the peptides obtained to a sequence database (ExPASy).


    Glycosylation of the peptide chains of the bovine LAMAN using SDS–PAGE
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
The peptide chains of the reduced and carboxymethylated bovine LAMAN were first electrophoretically separated, using SDS–PAGE, followed by in-gel deglycosylation using PNGase F and MALDI-MS analysis of the extracted products, as described previously (Küster et al., 1997Go). The results of the SDS–PAGE obtained were in accordance with those obtained by Tollersrud and co-workers (1997). Figure 3A shows the different peptides constituting the bovine LAMAN. Because of their similar molecular mass, the a- and d-peptides were observed as a mixture. The abc-, c-, b-, and e-peptide chains were mostly well separated and showed a great heterogeneity due probably to the heterogeneity of their carbohydrate moieties. The abc-peptide originates from an incomplete proteolytic cleavage of the mature 110 kDa precursor of the bovine LAMAN (Nilssen et al., 1997Go; Tollersrud et al., 1997Go).


Figure 3
View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3. MALDI-MS spectra of the in-gel PNGase F-released N-glycans from the SDS–PAGE separated abc (B), a/d (C), c (D), and e (E) peptides of the bovine LAMAN (A). The bovine LAMAN was reduced, alkylated, and then run on a 12.5% acrylamide gel. Bands of interest were then excised, destained, and in-gel deglycosylated by treatment with PNGase F. The extracted glycans were purified on nonporous graphitized carbon solid-phase extraction cartridge and characterized by MALDI-MS analysis, as [M+Na]+ pseudomolecular ions, before (E) and after on-plate exoglycosidase digestions on the glycans extracted from the e-peptide (F). Mass spectra were recorded in positive ion reflective mode. Symbols are as in Figure 1.

 
Figure 3B depicts the MALDI-MS spectrum of the in-gel-released glycans from the unprocessed abc-peptide of the bovine LAMAN, which contains the N133, N367, and N497 glycosylation sites. This spectrum is dominated by a strong signal at m/z 1257, corresponding to the Hex5HexNAc2 high-mannose-type glycan, accompanied by lower signals at m/z 1403 (dHex1Hex5HexNAc2), 1419 (Hex6HexNAc2), 1542 (Hex3HexNAc5), 1581 (Hex7HexNAc2), 1663 (Hex5HexNAc4), 1688 (dHex1Hex3HexNAc5), 1704 (Hex4HexNAc5), 1743 (Hex8HexNAc2), 1809 (dHex1Hex5HexNAc4), 1825 (Hex6HexNAc4), and 1850 (dHex1Hex4HexNAc5). All these species were in agreement with those expected and summarized in Figure 2. Owing to its low abundance, the core-fucosylated hybrid structure (dHex1Hex5HexNAc4) was not detected in the total pool of PNGase F-released N-glycans and was only observed when the individual peptide chains were studied. The expected evolutionary conserved Glc1Man9GlcNAc2 among LAMANs, which is located to the c-peptide, has not been detected because of its low abundance within the total pool of the abc-peptide-carried glycans. The N-glycans belong to the following three classes: high-mannose structures, hybrid structures, and complex-type structures. High-mannose structures are more abundant than hybrid-type structures and complex-type structures. The structures of the N-glycans were elucidated using on-target sequential exoglycosidase digestions (data not shown). The site-specific distribution of these structures cannot be elucidated since their respective peptide chains were unprocessed and then electrophoretically unseparated.

As depicted in Figure 3C, the MALDI-MS spectrum of the PNGase F-released oligosaccharides from the bands containing the mixed a- and d-peptides shows the presence of a great diversity of pseudomolecular ions [M+Na]+, corresponding to a monosaccharide composition consistent with oligomannosidic (Hex5–9HexNAc2), hybrid (Hex4–6HexNAc4), and complex (Fuc0–1Hex3–5HexNAc3–5) structures. These structures are in keeping with those observed from the total pool of the N-glycans. These data indicate that most of the N-glycans of the bovine LAMAN are on the a- (N133) and d- (N645, N651, N692, and N766) peptides.

The MALDI-MS spectrum, depicted in Figure 3D, of the PNGase F-released glycans from the c-peptide, which only contains the N497 site, was dominated by a strong signal at m/z 1905, which is consistent with the monosaccharide composition of Hex9HexNAc2, accompanied by lower signals at m/z 1257 (Hex5HexNAc2), 1419 (Hex6HexNAc2), 1581 (Hex7HexNAc2), 1743 (Hex8HexNAc2), and 2067 (Hex10HexNAc2). These oligomannosidic structures were confirmed by MALDI-MS analysis after on-plate {alpha}-mannosidase and {alpha}-glucosidase II treatments (data not shown). These data indicate that the c-peptide of the bovine LAMAN contains glycans having compositions consistent with high-mannose structures (Hex5–10HexNAc2), including the evolutionary conserved Glc1Man9GlcNAc2 glycan.

The MALDI-MS spectrum (Figure 3E) of the oligosaccharides released by PNGase F from the e-peptide, containing the N930 site, yielded two major pseudomolecular ions [M+Na]+ at m/z 1079 and 1257, compatible with a core-fucosylated trimannosyl structure dHex1Hex3HexNAc2 and an oligomannosidic structure Hex5HexNAc2, respectively. Three other pseudomolecular ions [M+Na]+ were observed at m/z 1095 (Hex4HexNAc2), 1419 (Hex6HexNAc2), and 1403 (dHex1Hex4,6HexNAc2). The in-gel-released oligosaccharides from the e-peptide were further submitted to on-plate sequential {alpha}-fucosidase digestion followed by MALDI-MS analysis (Figure 3F). After this treatment, both components dHex1Hex3HexNAc2 (m/z 1079) and dHex1Hex5HexNAc2 (m/z 1403) were efficiently digested to Hex3HexNAc2 (m/z 933) and Hex5HexNAc2 (m/z 1257), respectively. Taking into consideration the linkage analysis data, these results suggest that dHex1Hex3HexNAc2 and dHex1Hex5HexNAc2 are {alpha}(1,6)-core fucosylated.


    Site-specific glycosylation of the bovine LAMAN using concanavalin A immobilized affinity chromatography
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
To identify the site-specific glycosylation at the remaining N133, N367, N645, N651, N692, and N766 glycosylation sites, and to confirm the results obtained for the other N-glycosylation sites, glycopeptides obtained by tryptic digestion of the reduced and carboxamidomethylated bovine LAMAN were enriched by Con A immobilized affinity chromatography. Con A agglutinin is a plant lectin which binds to high-mannose-type and hybrid-type with high affinity. Complex-type N-glycans are also weakly bound to this lectin. Two Con A-Sepharose-bound fractions were obtained. Low-affinity fraction (F1), eluted with 10 mM {alpha}-methylglucopyranoside, containing glycopeptides with complex-type N-glycans, and high-affinity fraction (F2), eluted with 500 mM {alpha}-methylglucopyranoside, containing glycopeptides with oligomannosidic and hybrid-type N-glycans, were desalted on a C18 Sep-Pak cartridge. The glycopeptides from these fractions were finally separated by reverse-phase high-performance liquid chromatography (HPLC) (Figure 4). The fractions were collected, and each purified fraction was analyzed by MALDI–MS, in conjunction with on-target exoglycosidase digestions. Tryptic glycopeptides were then identified, based on theoretical masses of tryptic peptides from the reduced and carboxamidomethylated bovine LAMAN with various additional N-glycans. Based on MALDI-MS profiles, fractions F1-I and F1-II from the low-affinity (F1) and F2-I, F2-II, and F2-III from the high-affinity (F2) fractions bound by Con A-Sepharose correspond to glycopeptide fractions. Figures 5 and 6 show the MALDI mass spectra of fractions F1-I, F1-II, F2-I, F2-II, and F2-III. Subtraction of the calculated average mass of the predicted tryptic peptide from the average molecular mass of the glycopeptides observed provided the oligosaccharide residue compositions, summarized in Table III. As expected for most of them, the monosaccharide compositions of glycopeptides were consistent with those identified by the MALDI-MS analysis of the PNGase F-released glycans from the bovine LAMAN (Table I). However, the site-specific glycosylation, within the N766 and N692 glycosylation sites, for example, indicated the presence of some minor additional structures like dHex1Hex4HexNAc2 (m/z 3125) and dHex1Hex6HexNAc4 (m/z 4277) not listed in Table I.


Figure 4
View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4. Reverse-phase HPLC profiles of both the low- (A) and high- (B) affinity fractions obtained by Con A immobilized affinity chromatography. Bovine LAMAN was reduced, carboxamidomethylated, and subjected to a tryptic digestion. The resulting peptide/glycopeptide mixture was then chromatographied on a Con A-Sepharose affinity column, and the bound glycopeptides were eluted into low F1 (A) and high F2 (B) affinity fractions, respectively with 10 and 500 mM {alpha}-methylglucopyranoside. Con A-purified tryptic glycopeptides from each affinity fraction were fractionated using reverse-phase HPLC on an XTerra MS C18 (2.1 x 150 mm; 3.5 µm) column equilibrated in 0.1% (v/v) TFA at a flow rate of 0.125 mL/min, and the elution profile was followed by monitoring at 214 nm. The glycopeptide-containing fractions are indicated as F1-I, F1-II, F2-I, F2-II, and F2-III.

 

Figure 5
View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5. MALDI-MS spectra of the glycopeptides from the reverse-phase HPLC fractions F2-II before (A), after {alpha}-mannosidase treatment (B), and combined {alpha}-mannosidase and {alpha}-fucosidase (C) treatment. Native glycopeptides and digested products were analyzed, respectively as [M+H]+ and [M+Na]+ molecular ions in positive ion reflective mode. The monosaccharide compositions were deduced by subtraction of the calculated average mass of the predicted tryptic peptide from the average molecular mass of the observed glycopeptides. The compositional assignment of the molecular ions is listed in Table III. The carbohydrate structures correspond with those previously elucidated and summarized in Figure 2.

 

Figure 6
View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6. MALDI-MS spectra of the glycopeptides F1-I (A), F1-II (B), F2-I (C), F2-III (D). Low and high Con A-Sepharose affinity fractions were fractionated by reverse-phase HPLC, and the resulted fractions were analyzed by MALDI-MS. Glycopeptides were analyzed as [M+H]+ and [M+Na]+ molecular ions in positive ion reflective mode. The compositional assignment of the molecular ions is listed in Table III. Glycopeptides from the F1-I (A) and the F2-I (C) fractions were identified to contain the N766 glycosylation site and the F1-II (B) and the F2-III (D) fractions, the N692 glycosylation site.

 

View this table:
[in this window]
[in a new window]
 
Table III. Compositional assignment of the tryptic glycopeptides

 

To confirm the structure of their carbohydrate moiety, each glycopeptide was subjected to on-plate sequential exoglycosidase digestions, followed by MALDI-MS analysis, as illustrated in the case of glycopeptide from fraction F2-II in Figure 5. Finally, amino acid sequence of each glycopeptide was then obtained, after their deglycosylation using PNGase F, by nanoESI-MS/MS analysis (Figure 7).


Figure 7
View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7. CID-MS/MS mass spectrum of the parent ion at m/z 905, corresponding to the peptide moiety of the glycopeptide from the fraction F2-I. The glycopeptide from the fraction F2-I was deglycosylated using PNGase F The peptidic aglycone was then purified on C18 Zip-tip and analyzed by nanoESI-MS/MS under 40 eV as collision energy. The parent ion corresponds to the predicted mass of the tryptic peptide 366ANLSWSVK373 containing the N367 glycosylation site. The N367 residue was transformed in aspartic residue after PNGase F treatment.

 

For example, the MALDI-MS spectrum of the native glycopeptide from the high-affinity fraction F2-II, bound to Con A-Sepharose, depicted in the Figure 5A, shows molecular ions [M+H]+ at m/z 1797, 1943, 1959, 2121, 2267, and 2283, spaced by dHex units (146 Da) and by Hex units (162 Da). These signals were assignable to the predicted tryptic peptide 366ANLSWSVK373 with additional high-mannose structures, having compositions Hex3HexNAc2 (m/z 1797), dHex1Hex3HexNAc2 (m/z 1943), Hex4HexNAc2 (m/z 1959), Hex5HexNAc2 (m/z 2121), dHex1Hex5HexNAc2 (m/z 2267), and Hex6HexNAc2 (m/z 2283). To confirm the structure of the carbohydrate moiety, the glycopeptide was submitted to on-plate sequential exoglycosidase digestions, using {alpha}-mannosidase and/or {alpha}-fucosidase, followed by MALDI-MS (Figure 5B and C). After, {alpha}-mannosidase treatment, molecular ions [M+H]+ at m/z 1943, 1959, 2121, 2267, and 2283 disappeared, with a concomitant increase of protonated species [M+H]+ at m/z 1797 (dHex1Hex2HexNAc2) and a concomitant appearance of protonated species [M+H]+ at m/z 1634 (Hex2HexNAc2), 1618 (dHex1Hex1HexNAc2), and 1472 (Hex1HexNAc2). This experiment confirmed that all glycoforms present on the N367 glycosylation site corresponded to oligomannose-type N-glycans. These results are in good agreement with the results obtained by Tollersrud et al. (1997)Go. Moreover, the protonated species [M+H]+ at m/z 1618 (dHex1Hex1HexNAc2) and 1802 (dHex1Hex2HexNAc2) corresponded to products from the digestion of fucosylated high-mannose structures. To confirm the presence of a fucose residue, glycoforms of the tryptic peptide 366ANLSWSVK373 were then digested using {alpha}-mannosidase and {alpha}-fucosidase. As depicted in the MALDI-MS spectrum of the Figure 5C, molecular ions [M+H]+ at m/z 1618 and [M+Na]+ at m/z 1802 disappeared. Taking into consideration the linkage analysis data, these results indicate that both molecular species at m/z 1943 (dHex1Hex3HexNAc2) and 2267 (dHex1Hex5HexNAc2) were core fucosylated. Then, to identify the glycosylation site, the glycopeptide from the high-affinity fraction F2-II was deglycosylated using PNGase F, and the resulting aglycone was analyzed by nanoESI-MS/MS. The product ion spectrum CID-MS/MS (Figure 7) obtained from the nanoESI-MS spectrum was dominated by an intense signal at m/z 905 and is consistent with the theoretical mass of the predicted tryptic peptide 366ADLSWSVK373, containing the N367 glycosylation site. The parent ion was selected by the quadrupole and was subsequently fragmented in the collision cell, under 40 eV as collision energy. The CID-MS/MS spectrum in Figure 7 shows two series of singly charged B- and Y-type fragment ions, which fit to the theoretical masses of the product ions calculated from the predicted sequence 366ADLSWSVK373 containing the N367 glycosylation site. The asparagine residue was converted to an aspartic acid residue after PNGase F treatment.

Using the same experiments, site-specific glycosylation within the N766 and N692 glycosylation sites from the d-peptide of the bovine LAMAN was also determined, and both sites were occupied by broad glycan heterogeneity, since the corresponding glycopeptides were found in both the low- and high-affinity fractions. Figure 6A and C depicts MALDI-MS spectra of the native glycopeptides, containing the N766 site, isolated from the F1-I and F2-I affinity fractions, respectively. MALDI-MS spectrum of the native glycopeptides from the F1-I fraction (Figure 6A) is dominated by a strong signal at m/z 3545, corresponding to the predicted tryptic sequence 765LNQTEPVAGNYYPVNSR781 with additional Hex5HexNAc4 structure. About 10 molecular ions were also observed and correspond to the same predicted tryptic peptide with additional structures, ranging from agalactosylated biantennary to core-fucosylated and bisected biantennary structures, and/or triantennary structures. This result is consistent with the low affinity of the Con A lectin for the complex-type N-glycans. The MALDI-MS spectrum of the native glycopeptides from the F2-I fraction (Figure 6C) shows three strong signals at m/z 3141, 3303, and 3545. These molecular ions correspond to the predicted tryptic peptide 765LNQTEPVAGNYYPVNSR781 with additional Hex5HexNAc2, Hex6HexNAc2, and Hex5HexNAc4, respectively. About eight minor molecular species were also observed and correspond to the same peptide with additional high-mannose-type (dHex0–1Hex3–7HexNAc2) and hybrid-type (Hex4–6HexNAc4) N-glycans. The molecular species at m/z 3545 consists in the major component within the N766 site, since it is found with high abundance in both the high- and low-affinity fractions. All these structures were confirmed by on-target exoglycosidase digestions (data not shown).

The site-specific glycosylation within the N692 site has also been determined after MALDI-MS analysis of both the F1-II (Figure 6B) and F2-III (Figure 6D) affinity fractions, containing glycopeptides bearing the predicted amino acid sequence 683ASLVQEVHQNFSAWCSQVVR702. The MALDI-MS spectrum, depicted in Figure 6B, has two main species at m/z 3848 and 4010, corresponding to the predicted peptide attached respectively to agalactosylated and galactosylated bisected biantennary glycan. It is important to note that these molecular ions can also correspond to the predicted peptide attached to minor triantennary structures. Minor molecular ions were also observed and were consistent with biantennary glycoforms, ranging from agalactosylated to core-fucosylated and bisected structures, and/or triantennary structures, with two terminating galactose. The MALDI-MS analysis of the glycoforms from the F2-III affinity fraction (Figure 6D) showed the presence of abundant and heterogenous high-mannose-type glycans (Hex4–8HexNAc2) and hybrid-type glycans (dHex0,1Hex4–6HexNAc4). The presence of the original structure dHex1Hex6HexNAc4 was not detected because of its low abundance within the total pool of PNGase F-released N-glycans. These structures were also confirmed by on-target exoglycosidase digestions (data not shown).

No tryptic glycopeptides, corresponding to the N645 and N651 glycosylation sites (639QAFYWYNASTGNNLSSQASGAYIFRPNQNKPLFVSHWAQTHLVK682), from the d-peptide of bovine LAMAN, were found by the analysis of both affinity fractions. Therefore, the Con A-unretained material was also fractionated using reverse-phase HPLC, and the fractions were analyzed by MALDI-MS. No glycopeptides corresponding to these sites were found, suggesting that these sites may be unglycosylated or sparsely glycosylated.


    Distribution of the major PNGase F-released N-glycans at each N-glycosylation site
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
Taking into consideration mass spectrometric data obtained from the analysis of each peptide chain of the bovine LAMAN and tryptic Con A-Sepharose-enriched glycopeptides, we conclude that (1) most glycosylation sites are occupied by a broad diversity of carbohydrates; (2) the N645 and N651, from the d-peptide, appear to be sparsely glycosylated or unglycosylated; (3) The N367 site, from the b-peptide chain, is only glycosylated with oligomannosidic structures (Fuc0–1Man3–5GlcNAc2); (4) the N497site, from the c-peptide, is only occupied by high-mannose structures (Glc0–1Man5–9GlcNAc2), including the evolutionary conserved Glc1Man9GlcNAc2 glycan; (5) N692 and N766 sites from the d-peptide chain both bear glycans consisting in oligomannosidic (Man3–7GlcNAc2), hybrid (Fuc0–1Gal0–1Man4–5GlcNAc4), and complex (Fuc0–1Gal0–2Man3GlcNAc4–5) structures; and (6) the N930, from the e-peptide, contains only oligomannosidic-type glycans (Fuc0–1Man3–5GlcNAc2).

With respect to the N133, from the a-peptide, site-specific glycosylation can be conducted, taking into consideration the data obtained from the analysis of the in-gel-released glycans from the abc- and c-peptides and the tryptic glycopeptide containing the N367 site, belonging to the b-peptide. Indeed, among the pool of in-gel-released glycans from the abc-peptide (Figure 3B), complex- (Fuc0–1 Gal0–1Man3GlcNAc5) and hybrid-type (Fuc0–1Gal0–1 Man5GlcNAc4) N-glycans were present, while they were not found on both the N497 and N367 sites (Figures 3D and 5A). These structures can be assigned to the N133 glycosylation site. Besides, Tollersrud et al. (1997)Go demonstrated that the N-glycans on the N133 glycosylation site can be released using the endoH enzyme. Thus, the N133 site (a-peptide) is glycosylated as represented in Scheme 2, which also illustrates the site-specific distribution of the major PNGase F-released glycans from the bovine LAMAN within each glycosylation site.


Figure 2
View larger version (22K):
[in this window]
[in a new window]
 
Scheme 2. Proposed structures of the N-linked oligosaccharides at Asn-133, Asn-367, Asn-497, Asn-692, Asn-766, and Asn-930 from bovine LAMAN.

 


    Discussion
 Top
 Abstract
 Introduction
 Results
 O-glycosylation analysis
 Strategy for investigating site...
 Glycosylation of the peptide...
 Site-specific glycosylation of...
 Distribution of the major...
 Discussion
 Materials and Methods
 Conflict of interest statement
 Acknowledgments
 References
 
Most secretory and membrane-bound proteins produced by mammalian cells contain covalently linked oligosaccharide chains. Carbohydrate moieties can play important structural and functional roles in a glycoprotein such as immunogenicity, solubility, protein conformation, molecular recognition, intracellular trafficking, or protease resistance (Varki, 1993Go; Helenius and Aebi, 2001Go, 2004; Trombetta, 2003). They are involved in the proper folding of the newly synthesized nascent proteins within the ER, by interacting with the components of the control quality machinery (for reviews see Spiro, 2002Go; Helenius and Aebi, 2004Go; Trombetta and Parodi, 2005Go). It has been reported that glycosylation could also be essential for lysosomal stability and activity in some lysosomal hydrolases by maintaining correct protein conformation (Ferlinz et al., 2001Go; Wujek et al., 2004Go; Berg T, Hansen GM, et al., in preparation).

We have used bovine LAMAN as an interesting model for understanding the human glycoprotein as well as the pathophysiology of its defect-related disease, namely {alpha}-mannosidosis. This enzyme was shown to be glycosylated, and seven of the eight N-glycosylation sites were site occupied (Tollersrud et al., 1997Go; Heikinheimo et al., 2003Go). Apart from mediating lysosomal sorting and transport (Tollersrud et al., 1997Go; Heikinheimo et al., 2003Go) or maintaining lysosomal stability (Berg T, Hansen GM, et al., in preparation), the putative functions associated with its carbohydrates remained unknown. As a first step toward elucidation of N-glycan functions, we have initiated the complete structural elucidation of the major N-glycans as well as their site-specific distribution at each N-glycosylation site of bovine LAMAN. In this study, we first determined the structure of all N-linked glycans of the bovine LAMAN, summarized in Figure 2, as the major structures to be released by PNGase F. The major structures fall into three classes, namely high-mannose-type (Fuc0–1Glc0–1Man4–9GlcNAc2), hybrid-type (Gal0–1Man4–5GlcNAc4), and complex-type (Fuc0–1Gal0–2 Man3GlcNAc3–5) N-glycans, with or without core fucosylation and with or without bisecting GlcNAc (Figure 2). A minor monoglucosylated high-mannose N-glycan (Glc1Man9GlcNAc2) was also described and is consistent with the evolutionary conserved structure among LAMANs. High-mannose structures are more abundant than hybrid and complex structures. The major complex-type oligosaccharides have compositions consistent with biantennary structures with a bisecting GlcNAc residue or triantennary structures without ({alpha}1,6)-core fucosylation. The major nonreducing epitopes in the complex-type glycans are GlcNAc and Gal(ß1–4)GlcNAc. Thus, in the lysosomal environment of the bovine LAMAN, the oligosaccharides may undergo degradation to shorter chains. Indeed, since the high-mannose glycans represent potential substrates for the enzyme itself, some of the truncated and high-mannose glycans (Fuc0–1Man3–5GlcNAc2) may not represent native structures and may arise from high-mannose structures with a greater number of mannose residues. For example, truncated high-mannose structure Man4GlcNAc2 may be essentially obtained from LAMAN-digested hybrid-type Man4–5GlcNAc4 structures, which further lose their GlcNAc-terminated residues. This hypothesis is confirmed by the presence of core fucosylation on both Man4GlcNAc2 and Man5GlcNAc2 structures, which requires an unsubstituted GlcNAc residue (ß1,4)-linked to the {alpha}-Man residue of the ({alpha}1,3)-antennae of the N-glycan for the transfer (Harpaz and Schachter, 1980Go; Kornfeld and Kornfeld, 1985Go). Although ({alpha}1,6)-core fucosylation appears to be a terminal event occurring exclusively on complex or hybrid structures, there is growing evidence that core-fucosylated high-mannose structures can also occur in mammalian cells (Lin et al., 1994Go; Endo et al., 1996Go; Hoja-Lukowicz et al., 2000Go). In fact, some lysosomal glycoproteins, including porcine LAMAN, typically possessing a high content of high-mannose structures, were shown to carry core-fucosylated high-mannose-type N-glycans (Man5GlcNAc